Harikrishna Nakshatri

发表

PROGgeneV2: enhancements on the existing database

Chirayu Pankaj Goswami, Harikrishna Nakshatri, H. Nakshatri, 2014, BMC Cancer.

PROGgene: gene expression based survival analysis web application for multiple cancers

Chirayu Pankaj Goswami, Harikrishna Nakshatri, H. Nakshatri, 2013, Journal of Clinical Bioinformatics.

PROGmiR: a tool for identifying prognostic miRNA biomarkers in multiple cancers using publicly available data

Chirayu Pankaj Goswami, Harikrishna Nakshatri, H. Nakshatri, 2012, Journal of Clinical Bioinformatics.

Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse

Keith M. Stantz, Naomi J. Halas, Mi-Ran Choi, 2012, Cancer Nanotechnology.

Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently

Philippe Kastner, Sylvie Mader, Pierre Chambon, 1992, Cell.

Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model

Liang Cheng, Gary D Hutchins, Qi-Huang Zheng, 2006, The Prostate.

FOXA1 is an independent prognostic marker for ER-positive breast cancer

Samuel Leung, David Huntsman, Harikrishna Nakshatri, 2012, Breast Cancer Research and Treatment.

Genetic Ancestry–dependent Differences in Breast Cancer–induced Field Defects in the Tumor-adjacent Normal Breast

Harikrishna Nakshatri, George E. Sandusky, Crislyn D'Souza-Schorey, 2019, Clinical Cancer Research.

Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer

Harikrishna Nakshatri, H. Nakshatri, C. Sweeney, 2004, Investigational New Drugs.

FOXA1 Expression in Breast Cancer—Correlation with Luminal Subtype A and Survival

Charles M Perou, Dmitry Turbin, Harikrishna Nakshatri, 2007, Clinical Cancer Research.

Estradiol-regulated microRNAs control estradiol response in breast cancer cells

Guohua Wang, Jason S. Carroll, Harikrishna Nakshatri, 2009, Nucleic acids research.

Individualized Breast Cancer Characterization through Single-Cell Analysis of Tumor and Adjacent Normal Cells.

Susan Rice, Yan Dong, Lijun Cheng, 2017, Cancer research.

Breast cancer stem cells and intrinsic subtypes: controversies rage on.

Harikrishna Nakshatri, Sunil Badve, S. Badve, 2009, Current stem cell research & therapy.

SLUG/SNAI2 and Tumor Necrosis Factor Generate Breast Cells With CD44+/CD24- Phenotype

Harikrishna Nakshatri, Sunil Badve, Poornima Bhat-Nakshatri, 2010, BMC Cancer.

Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients

Harikrishna Nakshatri, Sunil Badve, Yunlong Liu, 2011, Breast Cancer Research.

Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase

Harikrishna Nakshatri, Poornima Bhat-Nakshatri, H. Nakshatri, 2004, Oncogene.

Nuclear Factor-κB Is Constitutively Activated in Prostate Cancer In vitro and Is Overexpressed in Prostatic Intraepithelial Neoplasia and Adenocarcinoma of the Prostate

Liang Cheng, Lang Li, Harikrishna Nakshatri, 2004, Clinical Cancer Research.

Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity

George W. Sledge, Harikrishna Nakshatri, Sunil Badve, 2013, Scientific Reports.

Identity profiling of cell surface markers by multiplex gold nanorod probes.

Joseph Irudayaraj, Harikrishna Nakshatri, Chenxu Yu, 2007, Nano letters.

Microfluidic channel for characterizing normal and breast cancer cells

Joseph M. Wallace, Mangilal Agarwal, Hiroki Yokota, 2017 .

Virtual screening targeting the urokinase receptor, biochemical and cell-based studies, synthesis, pharmacokinetic characterization, and effect on breast tumor metastasis.

Jing Li, George W. Sledge, Samy O. Meroueh, 2011, Journal of medicinal chemistry.

NF-kappaB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapy.

Menggang Yu, Harikrishna Nakshatri, Poornima Bhat-Nakshatri, 2009, Cancer letters.

A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco‐associated cancers, lung and bladder cancer, by targeting NF‐κB and generating reactive oxygen species

Peter Crooks, Liang Cheng, Harikrishna Nakshatri, 2011, International journal of cancer.

CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis

Harikrishna Nakshatri, Sunil Badve, Poornima Bhat-Nakshatri, 2006, Breast Cancer Research.

A water‐soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFκB and generating reactive oxygen species

Peter Crooks, Liang Cheng, Harikrishna Nakshatri, 2010, The Prostate.

Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells

Peter Crooks, Harikrishna Nakshatri, Sunil Badve, 2015, Oncotarget.

Antimyeloma Effects of a Sesquiterpene Lactone Parthenolide

Harikrishna Nakshatri, H. Nakshatri, H. Boswell, 2008, Clinical Cancer Research.

FOXA1 in breast cancer

Harikrishna Nakshatri, Sunil Badve, S. Badve, 2009, Expert Reviews in Molecular Medicine.